CS74890A2 - Pharmaceutical for tonsilitis prophylaxis and/ or therapy - Google Patents
Pharmaceutical for tonsilitis prophylaxis and/ or therapy Download PDFInfo
- Publication number
- CS74890A2 CS74890A2 CS90748A CS74890A CS74890A2 CS 74890 A2 CS74890 A2 CS 74890A2 CS 90748 A CS90748 A CS 90748A CS 74890 A CS74890 A CS 74890A CS 74890 A2 CS74890 A2 CS 74890A2
- Authority
- CS
- Czechoslovakia
- Prior art keywords
- ncib
- strains
- streptococci
- strain
- pharmaceutical composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
- Y10S435/885—Streptococcus
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE8900510A SE463349B (sv) | 1989-02-15 | 1989-02-15 | Farmaceutiskt preparat foer profylax mot och/eller behandling av beta-streptokockinducerad tonsillit |
Publications (1)
Publication Number | Publication Date |
---|---|
CS74890A2 true CS74890A2 (en) | 1991-09-15 |
Family
ID=20375049
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CS90748A CS74890A2 (en) | 1989-02-15 | 1990-02-15 | Pharmaceutical for tonsilitis prophylaxis and/ or therapy |
Country Status (28)
Country | Link |
---|---|
US (1) | US5378459A (de) |
EP (1) | EP0458855B1 (de) |
CN (1) | CN1046099A (de) |
AR (1) | AR247099A1 (de) |
AT (1) | ATE142503T1 (de) |
AU (1) | AU628493B2 (de) |
CA (1) | CA2047189A1 (de) |
CS (1) | CS74890A2 (de) |
DD (1) | DD291926A5 (de) |
DE (1) | DE69028520T2 (de) |
DK (1) | DK0458855T3 (de) |
EG (1) | EG19075A (de) |
ES (1) | ES2091818T3 (de) |
FI (1) | FI101452B (de) |
GR (1) | GR1000639B (de) |
HU (1) | HU209915B (de) |
IE (1) | IE900459L (de) |
IL (1) | IL93242A (de) |
IS (1) | IS1678B (de) |
MY (1) | MY106487A (de) |
NO (1) | NO178883C (de) |
NZ (1) | NZ232381A (de) |
PH (1) | PH27203A (de) |
PT (1) | PT93141A (de) |
SE (1) | SE463349B (de) |
WO (1) | WO1990009186A1 (de) |
YU (1) | YU23490A (de) |
ZA (1) | ZA90692B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5705152A (en) * | 1990-10-26 | 1998-01-06 | Interprise Limited | Antimicrobial composition |
AUPN698495A0 (en) * | 1995-12-06 | 1996-01-04 | Pharma Pacific Pty Ltd | Improved therapeutic formulation and method |
SE511648C2 (sv) * | 1998-04-17 | 1999-11-01 | Bacterum Ab | Streptokockpreparat för behandling av öroninflammation |
RU2279481C2 (ru) * | 1999-10-12 | 2006-07-10 | Блис Текнолоджис Лимитед | Лантибиотик |
DE10139039A1 (de) * | 2001-08-08 | 2003-05-08 | Zinon Douvlis | Medikamentöse Suppression maligner Proliferationsprozesse durch Aminosäuren und Aminosäurenbindungen orientierte Reaktionen |
WO2010056198A1 (en) | 2008-11-17 | 2010-05-20 | Essum Ab | Pharmaceutical preparation comprising a combination of streptococcus strains and lactobacillus strains |
WO2017054084A1 (en) | 2015-10-01 | 2017-04-06 | The Governing Council Of The University Of Toronto | Iron-fortified tea preparations |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4454109A (en) * | 1981-02-17 | 1984-06-12 | Forsyth Dental Infirmary For Children | Method of treating periodontosis |
CA1195613A (en) * | 1981-02-17 | 1985-10-22 | Forsyth Dental Infirmary For Children | Method of treating periodontosis |
JPS5927833A (ja) * | 1982-08-06 | 1984-02-14 | Advance Res & Dev Co Ltd | コレステロール乃至トリグリセリド低下剤 |
-
1989
- 1989-02-15 SE SE8900510A patent/SE463349B/sv not_active IP Right Cessation
-
1990
- 1990-01-30 ZA ZA90692A patent/ZA90692B/xx unknown
- 1990-02-01 IL IL9324290A patent/IL93242A/en not_active IP Right Cessation
- 1990-02-05 NZ NZ232381A patent/NZ232381A/en unknown
- 1990-02-07 YU YU23490A patent/YU23490A/sh unknown
- 1990-02-08 PH PH40021A patent/PH27203A/en unknown
- 1990-02-09 IE IE900459A patent/IE900459L/xx unknown
- 1990-02-12 DK DK90903444.9T patent/DK0458855T3/da active
- 1990-02-12 AT AT90903444T patent/ATE142503T1/de not_active IP Right Cessation
- 1990-02-12 HU HU901920A patent/HU209915B/hu not_active IP Right Cessation
- 1990-02-12 ES ES90903444T patent/ES2091818T3/es not_active Expired - Lifetime
- 1990-02-12 EP EP90903444A patent/EP0458855B1/de not_active Expired - Lifetime
- 1990-02-12 WO PCT/SE1990/000089 patent/WO1990009186A1/en active IP Right Grant
- 1990-02-12 AU AU51577/90A patent/AU628493B2/en not_active Ceased
- 1990-02-12 CA CA002047189A patent/CA2047189A1/en not_active Abandoned
- 1990-02-12 GR GR900100092A patent/GR1000639B/el unknown
- 1990-02-12 DE DE69028520T patent/DE69028520T2/de not_active Expired - Fee Related
- 1990-02-13 EG EG7290A patent/EG19075A/xx active
- 1990-02-14 IS IS3547A patent/IS1678B/is unknown
- 1990-02-14 DD DD90337852A patent/DD291926A5/de unknown
- 1990-02-14 PT PT93141A patent/PT93141A/pt not_active Application Discontinuation
- 1990-02-15 AR AR90316173A patent/AR247099A1/es active
- 1990-02-15 CN CN90101773A patent/CN1046099A/zh active Pending
- 1990-02-15 CS CS90748A patent/CS74890A2/cs unknown
- 1990-02-15 MY MYPI90000256A patent/MY106487A/en unknown
-
1991
- 1991-08-13 NO NO913162A patent/NO178883C/no not_active IP Right Cessation
- 1991-08-14 FI FI913845A patent/FI101452B/fi active
-
1994
- 1994-02-10 US US08/194,753 patent/US5378459A/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU772332B2 (en) | Probiotic, lactic acid-producing bacteria and uses thereof | |
Brook et al. | Treatment of patients with a history of recurrent tonsillitis due to group A beta-hemolytic streptococci: A prospective randomized study comparing penicillin, erythromycin, and clindamycin | |
US20100291041A1 (en) | Bacteriophage preparation and use | |
Hoppe et al. | Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis | |
CS74890A2 (en) | Pharmaceutical for tonsilitis prophylaxis and/ or therapy | |
EP1894995B1 (de) | Irilis-biopräparation auf der basis von darin enthaltenen bacillus-bakterienstämmen bacillus subtilis und bacillus licheniformis | |
Gudmundsson et al. | Decreased bactericidal activity during the period of the postantibiotic effect | |
US5658887A (en) | Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivatite | |
CA3088890A1 (en) | Bacteriophage compositions for treating pseudomonas infections | |
Sanford et al. | Oxolinic acid in the treatment of typhoid fever due to chloramphenicol-resistant strains of Salmonella typhi | |
Kline et al. | Comparative in-vitro activity of LY146032 and eight other antibiotics against gram-positive bacteria isolated from children | |
Schaad et al. | Mecillinam alleine und kombiniert mit Ampicillin oder Moxalactam in experimenteller Escherichia coli-Meningitis | |
Sanders et al. | The role of normal throat flora in resistance to infection by group A streptococci | |
Raz et al. | Clindamycin in the treatment of an outbreak of streptococcal pharyngitis in a kibbutz due to beta-lactamase producing organisms | |
Fu et al. | Efficacy of rifampicin in experimental Bacteroides fragilis and Pseudomonas aeruginosa mixed infections | |
Tanphaichitra et al. | Kombination von Pivmecillinam und Pivampicillin zur Behandlung des Typhus | |
DAY et al. | 2, 6-dimethoxyphenol penicillin in infants and children: Preliminary studies | |
Hewitt | Effect of chemotherapeutic agents on C. diphtheriae, with special reference to the diamidines | |
Brook | Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice | |
JPH04503511A (ja) | 扁桃炎治療用薬学的調製物 |